|
BBS10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.02699999999334E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.958400E-04 |
| Normal-vs-Stage2 |
2.805900E-02 |
| Normal-vs-Stage3 |
1.33479999997466E-06 |
| Normal-vs-Stage4 |
9.35110000543915E-08 |
| Stage1-vs-Stage2 |
6.510400E-01 |
| Stage1-vs-Stage3 |
2.891700E-02 |
| Stage1-vs-Stage4 |
5.162800E-04 |
| Stage2-vs-Stage3 |
5.139700E-02 |
| Stage2-vs-Stage4 |
4.403500E-03 |
| Stage3-vs-Stage4 |
1.682170E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.80079999999783E-05 |
| Normal-vs-AfricanAmerican |
1.584080E-02 |
| Normal-vs-Asian |
8.030200E-04 |
| Caucasian-vs-AfricanAmerican |
7.242400E-01 |
| Caucasian-vs-Asian |
9.771400E-01 |
| AfricanAmerican-vs-Asian |
7.309200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.44569999971367E-07 |
| Normal-vs-Female |
2.759300E-04 |
| Male-vs-Female |
1.977770E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.830800E-04 |
| Normal-vs-Age(41-60Yrs) |
4.365400E-04 |
| Normal-vs-Age(61-80Yrs) |
8.38750000009547E-07 |
| Normal-vs-Age(81-100Yrs) |
2.858400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.467000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.057900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.088500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.692970E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.028600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.877200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.762200E-02 |
| Classical-VS-Follicular |
3.147000E-01 |
| Classical-VS-Other |
9.286000E-01 |
| Classical-VS-Normal |
8.20160000000181E-05 |
| Tall-VS-Follicular |
1.219770E-02 |
| Tall-VS-Other |
2.807600E-01 |
| Tall-VS-Normal |
4.90819999998671E-06 |
| Follicular-VS-Other |
8.257400E-01 |
| Follicular-VS-Normal |
1.334430E-02 |
| Other-VS-Normal |
1.676250E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.202300E-04 |
| Normal-vs-N1 |
1.54333999999867E-05 |
| N0-vs-N1 |
7.747800E-02 |
|
|
